Skip to main content
Journal of Medical Genetics logoLink to Journal of Medical Genetics
. 1996 Oct;33(10):809–813. doi: 10.1136/jmg.33.10.809

The epidemiology of anotia and microtia.

J Harris 1, B Källén 1, E Robert 1
PMCID: PMC1050757  PMID: 8933331

Abstract

We studied a large data set from three registries of congenital malformations (central-east France, Sweden, and California), a total of 954 cases, known chromosome anomalies excluded. The prevalence at birth varied significantly between programmes, probably to a large extent because of different ascertainment and inclusion criteria, from 0.76 per 10,000 births in the French programme to 2.35 in the Swedish. Within the California programme, there is a racial variability in prevalence with lower values among whites (and probably blacks) than in Hispanics and Asians. Also the proportion of anotia and microtia varies between races with the lowest proportion of anotia in whites. Anotia and microtia are equally often associated with other malformations and show other similar epidemiological characteristics. In unilateral cases, the right side is more frequently malformed than the left side, especially when the ear malformation is isolated. There is a male excess, most pronounced in isolated forms. Among associated malformations, facial clefts and cardiac defects are the most common ones (each about 30% of infants with associated malformations), followed by anophthalmia or microphthalmia (14%), limb reduction defects or severe renal malformations (11%), and holoprosencephaly (7%). There is a maternal parity effect seen, an increased risk at parity 4+ (standardised for maternal age), more pronounced for anotia than microtia.

Full text

PDF
809

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Castilla E. E., Orioli I. M. Prevalence rates of microtia in South America. Int J Epidemiol. 1986 Sep;15(3):364–368. doi: 10.1093/ije/15.3.364. [DOI] [PubMed] [Google Scholar]
  2. Croen L. A., Shaw G. M., Jensvold N. G., Harris J. A. Birth defects monitoring in California: a resource for epidemiological research. Paediatr Perinat Epidemiol. 1991 Oct;5(4):423–427. doi: 10.1111/j.1365-3016.1991.tb00728.x. [DOI] [PubMed] [Google Scholar]
  3. Fyler D. C. Cardiac catheterization, cardiac surgery, and the newborn infant-1969. Pediatrics. 1969 Jul;44(1):4–4. [PubMed] [Google Scholar]
  4. Källén B. Search for teratogenic risks with the aid of malformation registries. Teratology. 1987 Feb;35(1):47–52. doi: 10.1002/tera.1420350108. [DOI] [PubMed] [Google Scholar]
  5. Lynberg M. C., Khoury M. J., Lammer E. J., Waller K. O., Cordero J. F., Erickson J. D. Sensitivity, specificity, and positive predictive value of multiple malformations in isotretinoin embryopathy surveillance. Teratology. 1990 Nov;42(5):513–519. doi: 10.1002/tera.1420420508. [DOI] [PubMed] [Google Scholar]
  6. MANTEL N., HAENSZEL W. Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst. 1959 Apr;22(4):719–748. [PubMed] [Google Scholar]
  7. Mastroiacovo P., Corchia C., Botto L. D., Lanni R., Zampino G., Fusco D. Epidemiology and genetics of microtia-anotia: a registry based study on over one million births. J Med Genet. 1995 Jun;32(6):453–457. doi: 10.1136/jmg.32.6.453. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Robert E., Francannet C., Robert J. M. Le registre de malfromations de la région Rhône-Alpes/Auvergne. Intéret et limites de la tératovigilance. Onze ammées d'experience (1976-1986). J Gynecol Obstet Biol Reprod (Paris) 1988;17(5):601–607. [PubMed] [Google Scholar]
  9. Smithells R. W., Newman C. G. Recognition of thalidomide defects. J Med Genet. 1992 Oct;29(10):716–723. doi: 10.1136/jmg.29.10.716. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Journal of Medical Genetics are provided here courtesy of BMJ Publishing Group

RESOURCES